Typicality: | 0.490 |
Saliency: | 0.258 |
in 1952 | 4 | temporal |
vaccine → be developed by → jonas salk | 10 |
vaccine → be developed by → dr. jonas salk | 7 |
vaccine → be developed by → salk | 3 |
negative | neutral | positive |
0.108 | 0.552 | 0.339 |
Raw frequency | 20 |
Normalized frequency | 0.258 |
Modifier score | 0.900 |
Perplexity | 54.579 |